CAMBRIDGE MOLECULAR DIAGNOSTICS LTD

Company number 09600771

Date	Type	Description	View / Download
09 Sep 2024	AP02	Appointment of Reencara Limited as a director on 4 June 2024	(2 pages)
09 Sep 2024	TM01	Termination of appointment of Isosceles Finance Ltd as a director on 4 June 2024	(1 page)
07 Jun 2024	AA	Total exemption full accounts made up to 31 January 2024	(13 pages) Download iXBRL
29 Feb 2024	CS01	Confirmation statement made on 17 February 2024 with updates	(8 pages)
24 Oct 2023	PSC04	Change of details for Mr Gustavo Cerda Moya as a person with significant control on 4 October 2023	(2 pages)
05 Oct 2023	SH01	Statement of capital following an allotment of shares on 4 October 2023 GBP 978	(5 pages)
13 Sep 2023	RESOLUTIONS	Resolutions RES10 ‐ Resolution of allotment of securities RES01 ‐ Resolution of adoption of Articles of Association RES11 ‐ Resolution of removal of pre-emption rights	(2 pages)
04 Sep 2023	MA	Memorandum and Articles of Association	(14 pages)
22 May 2023	AA	Total exemption full accounts made up to 31 January 2023	(13 pages) Download iXBRL
17 Feb 2023	CS01	Confirmation statement made on 17 February 2023 with updates	(6 pages)
07 Feb 2023	TM01	Termination of appointment of Sam Hussain as a director on 6 February 2023	(1 page)
07 Feb 2023	TM01	Termination of appointment of Barrington William Burles as a director on 6 February 2023	(1 page)
31 Jan 2023	AA01	Previous accounting period shortened from 31 March 2023 to 31 January 2023	(1 page)
12 Sep 2022	SH01	Statement of capital following an allotment of shares on 15 August 2022 GBP 637.2	(3 pages)
08 Aug 2022	AA	Total exemption full accounts made up to 31 March 2022	(13 pages) Download iXBRL
27 Jul 2022	RESOLUTIONS	Resolutions RES11 ‐ Resolution of removal of pre-emption rights RES10 ‐ Resolution of allotment of securities	(1 page)
22 Jun 2022	AP01	Appointment of Mr Denis Francis Kinane as a director on 20 June 2022	(2 pages)
28 May 2022	CS01	Confirmation statement made on 20 May 2022 with updates	(4 pages)
03 Mar 2022	AA01	Current accounting period shortened from 31 May 2022 to 31 March 2022	(1 page)
27 Nov 2021	AA	Total exemption full accounts made up to 31 May 2021	(13 pages) Download iXBRL
07 Jun 2021	CS01	Confirmation statement made on 20 May 2021 with updates	(6 pages)
25 Mar 2021	AA	Total exemption full accounts made up to 31 May 2020	(10 pages) Download iXBRL
09 Oct 2020	RESOLUTIONS	Resolutions RES11 ‐ Resolution of removal of pre-emption rights	(1 page)
29 Sep 2020	SH01	Statement of capital following an allotment of shares on 3 July 2020 GBP 541.2	(3 pages)
25 Sep 2020	AD01	Registered office address changed from Department of Genetics Downing Street Cambridge CB2 3EH England to 25 Science Park, Bio-Innovation Centre Milton Road Cambridge CB4 0FW on 25 September 2020	(1 page)